Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
30th Annual Meeting of the ISCP
Author(s): Manuel Sánchez Suárez , Alberto Alen Andrés , Andrés Álvarez , et al Added: 1 month ago

Prevention & Chronic Conditions

Heart Failure
Symptomology, Outcomes and Risk Factors of Acute Coronary Syndrome Presentations without Cardiac Chest Pain: A Scoping Review
Author(s): Meriem Perona , Amanda Cooklin , Christopher Thorpe , et al Added: 1 year ago

MI/ACS
30th Annual Meeting of the ISCP
Author(s): Raúl Ludeña , Raúl Ptaszynski Lanza , Francisco González , et al Added: 1 month ago

Inherited and Congenital Cardiac Conditions

Prevention & Chronic Conditions
POTS-associated Conditions and Management Strategies
Author(s): Alexis Cutchins , Svetlana Blitshteyn , Rebecca Steinberg Added: 2 years ago
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited, and there are a multitude of associated conditions with overlapping symptoms which can make the diagnosis and management of POTS a difficult experience for providers and patients alike.This broadcast… View more

Electrophysiology & Arrhythmia

COVID-19
ESC 25: EMORI-HCM: Electromagnetically Optimised Right Ventricular Pacing for oHCM
Author(s): Ahran D Arnold Added: 8 months ago
ESC Congress 2025 - EMORI-HCM finds that right ventricular pacing (iRVP) improves symptoms in obstructive hypertrophic cardiomyopathy (oHCM) patients.Dr Ahran Arnold (Imperial College London, UK) discusses findings from the EMORI-HCM study, exploring electro-mechanically optimised right ventricular pacing as a novel therapeutic approach for patients with oHCM.This interventional trial examined… View more

Intervention

Electrophysiology & Arrhythmia
Recognising Undiagnosed Heart Failure in Women
Author(s): Renate B Schnabel , Eva Gerdts , Added: 8 months ago
Cardiovascular disease in women is frequently underdiagnosed, with heart failure often overlooked due to subtle symptoms and persistent clinical bias. In this on-demand symposium, leading experts explore why cardiovascular disease is missed in women, the unique risks and presentations of female heart failure and how early detection of atrial fibrillation can improve outcomes. Chaired by Prof… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
NY Valves 25: TRISCEND II Substudy
Author(s): Added: 10 months ago
New York Valves 25 - A substudy of TRISCEND II investigating the effect of transcatheter tricuspid valve replacement (TTVR) on preference-weighted health status showed significant benefits in patients who received TTVR.We are joined by Dr Suzanne Arnold (Saint Luke's Mid America Heart Institute, US) to discuss the findings from a substudy of the TRISCEND II trial, which aimed to create an… View more

Intervention
ACC 26: RECOVER-Autonomic - Ivabradine for Post-COVID POTS
Author(s): Pam Taub Added: 1 month ago
American College of Cardiology Congress 2026 – Dr Pam Taub (University of California San Diego, La Jolla, US) joins us to discuss results from the RECOVER-Autonomic platform trial (NCT06305806; Kanecia Obie Zimmerman), evaluating the impact of ivabradine on orthostatic intolerance, quality of life, and heart rate in post-COVID POTS.This randomised, placebo-controlled appendix trial enrolled 181… View more

Prevention & Chronic Conditions

COVID-19
Clinical Clues in Cardiovascular Disease
Author(s): Eva Gerdts , Faizel Osman , Yassir Javaid Added: 8 months ago
This six-part interview series, recorded around ESC 2025, brings together leading experts to share strategies for earlier and more accurate detection of cardiovascular disease. The discussions highlight how atypical or subtle symptoms of stroke and heart failure can delay diagnosis, and why vigilance in routine practice is critical.The series also examines sex-specific differences in cardiac… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
AHA 24: The ENDEAVOR Trial
Author(s): Added: 1 year ago
AHA Conference 2024 - Primary safety and efficacy results from ENDEAVOR investigating the effect of myeloperoxidase inhibition with mitiperstat (AstraZeneca) on symptoms and exercise capacity in patients with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF).Dr Sanjiv Shah (Bluhm Cardiovascular Institute, Chicago, US) joins us onsite at AHA Conference to discuss the… View more

Heart Failure